A mother whose newborn son almost died after contracting a respiratory virus is warning others not to its "underestimate" ...

"Clesrovimab administered as a single dose for infants of all weights provided protection against mild, moderate, and severe ...

Merck said on Thursday its experimental antibody therapy, clesrovimab, demonstrated a 60.4% effectiveness in reducing some ...

There is also a vaccine called Abrysvo under the brand name and RSVpreF under the generic name, for pregnant women between 32 ...

RSV is a virus that can make people sick, especially older adults and babies. But even though RSV can be serious, people aren ...

Clesrovimab, formerly known as MK-1654, is an extended half-life RSV fusion glycoprotein neutralizing monoclonal antibody.

Respiratory syncytial virus (RSV) season has begun in our area, and we are already seeing babies being hospitalized. RSV is a ...

Health experts highlight how this highly contagious disease affects vulnerable populations and share insights on prevention ...

Each year, 100,000 older US adults and 58,000 infants and children younger than 5 years are hospitalized for RSV, and 6,000 ...

WellSpan Ephrata Community Hospital is now offering respiratory syncytial virus immunizations to infants born at the hospital ...

Some Ontario doctors have started offering a free shot that can protect babies from respiratory syncytial virus while Quebec will begin its immunization program next month.

(Corrects headline, paragraph 1 and 2 in Oct. 17 story to show the drug reduced medically attended lower respiratory ...